ID   FHs 74 Int
AC   CVCL_2899
SY   FHs74Int; FHs74 Int; 74Int
DR   CLO; CLO_0003245
DR   AddexBio; P0021002/4996
DR   ATCC; CCL-241
DR   BioSample; SAMN03471479
DR   BioSample; SAMN03472360
DR   GEO; GSE11678
DR   Wikidata; Q54834900
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
CC   Characteristics: Can undergo 15 PDL.
CC   Doubling time: 6-7 days (PubMed=176412); 65 hours (with EGF), 168 hours (without EGF) (JCRB).
CC   Caution: Could be identical to Hs 74.Int (CVCL_S089).
CC   Misspelling: 741Int; In PubMed=761205.
ST   Source(s): AddexBio; ATCC; JCRB
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 7,9.3 (AddexBio; ATCC)
ST   TH01: 7,9.3,11 (JCRB)
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   12-16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-07-19; Version: 15
RX   PubMed=176412; DOI=10.1093/jnci/56.4.843;
RA   Owens R.B., Smith H.S., Nelson-Rees W.A., Springer E.L.;
RT   "Epithelial cell cultures from normal and cancerous human tissues.";
RL   J. Natl. Cancer Inst. 56:843-849(1976).
RX   PubMed=283258; DOI=10.1093/jnci/62.2.225;
RA   Smith H.S.;
RT   "In vitro properties of epithelial cell lines established from human
RT   carcinomas and nonmalignant tissue.";
RL   J. Natl. Cancer Inst. 62:225-230(1979).
RX   PubMed=761205;
RA   Smith H.S., Springer E.L., Hackett A.J.;
RT   "Nuclear ultrastructure of epithelial cell lines derived from human
RT   carcinomas and nonmalignant tissues.";
RL   Cancer Res. 39:332-344(1979).